Beruflich Dokumente
Kultur Dokumente
2.
y Changes associated with y Client was able to hypokalemia include verbalize abnormalities in both conduction and understanding of contractility. causative factors Tachycardia may develop, and and purpose of potentially life-threatening interventions and atrial and ventricular dysrhythmias, medications. e.g., PVCs, sinus bradycardia, atrioventricular (AV) blocks, AV y Client was able to dissociation, ventricular tachycardia. demonstrate behaviors to monitor and correct deficit. y Guide for calculating fluid/potassium replacement needs.
LONG-TERM: 1. To achieve fluid volume at a functional level as evidenced by laboratory results of patient.
y Maintain accurate record of urinary, gastric, and wound losses. y Monitor rate of IV potassium administration using microdrop or pump infusion devices. Check for side effects. Provide ice pack as indicated.
y Ensures controlled delivery of medication to prevent bolus effect y Client was able to and reduce associated discomfort, achieve fluid volume e.g., burning sensation at IV site. at functional level as When solution cannot be evidenced by administered via central vein and laboratory results of slowing rate is not patient. possible/effective, ice pack to infusion site may help relieve discomfort.
y Low potassium enhances effect of digitalis, slowing cardiac conduction. Note: Combined effects of digitalis, diuretics, and hypokalemia may produce lethal dysrhythmias.
laboratory
y Levels should be checked frequently during replacement therapy, especially in the presence of insufficient renal function. Sudden excess/elevation may cause cardiac dysrhythmias. Correction of metabolic alkalosis raises serum potassium level and reduces replacement needs. Correction of acidosis drives potassium back into cells, resulting in decreased serum levels and increased replacement needs.
ABGs;